Northrop Booked A B-21 Test Plane Sale As Revenue, But The $371 Million Of Cash Landed In Investing

The 10-Q puts the cash outside operations, while a redefined adjusted free cash flow figure now counts it.

Share
Northrop Booked A B-21 Test Plane Sale As Revenue, But The $371 Million Of Cash Landed In Investing

Northrop Grumman's 10-Q shows $371 million received for selling a B-21 test aircraft to a customer, booked as revenue but reported as cash from investing activities. The company's adjusted free cash flow measure, which counts that money, was $965 million for nine months against $72 million a year earlier.

Revenue on the income statement, investing in the cash flow

The filing says Northrop usually classifies proceeds from revenue transactions as operating cash. Here it did the opposite, consistent with how it had booked the cost of building the asset as capital spending.

The filing says the company previously meant to use the test asset internally, so it recorded the acquisition costs as capital expenditures. Since selling such equipment is routine for Northrop, the deal was treated as revenue, with the asset's net book value going into operating costs and expenses.

The company received the $371 million in the third quarter of 2026, according to the filing. The prior quarter's 10-Q said it had no material cash inflows from the sale in the first quarter.

The adjusted free cash flow math

In the earnings release, the company defines adjusted free cash flow as operating cash flow, less capital spending, plus proceeds from selling equipment to a customer. It says it includes those proceeds because they came from a customer sales transaction.

For nine months, operating cash flow was $1,369 million and capital spending $775 million. With the $371 million added, adjusted free cash flow was $965 million.

Third-quarter adjusted free cash flow rose 44% to $1.81 billion from $1.256 billion. The release attributes the rise to the sale proceeds and higher operating cash flow, which grew 12% to $1.745 billion on better trade working capital.

The prior quarter's filing reported adjusted free cash flow of negative $845 million for six months.

Cash, buybacks and the B-21 backdrop

Cash stood at $3.7 billion on September 30, against $2.3 billion on June 30. No shares were repurchased in the third quarter, and $2.5 billion of authorization remains.

The sale followed a first-quarter agreement with the Air Force to expand B-21 production capacity. Northrop continues to expect to invest about $2.5 billion over several years in that expansion, for the chance at better returns on later production lots.

At September 30, about $1.0 billion remained in the B-21 loss accrual, out of roughly $2.0 billion of cumulative losses recognized on the early production phase.

Guidance and the budget calendar

The company kept 2026 adjusted free cash flow guidance at $3.1 billion to $3.5 billion. It raised segment operating income guidance to $4.94 billion to $5.04 billion from $4.85 billion to $5.0 billion.

A continuing resolution enacted September 2 funds the government through December 11 at 2026 levels. The 10-Q says a shutdown could occur if it is not extended or replaced by full-year appropriations.

The next date that matters is December 11, when the continuing resolution funding the government expires.

Sources

More on Northrop Grumman

All Northrop Grumman (NOC) coverage →